Kalsiom
Biotech developing monoclonal antibodies that modulate calcium signaling in B cells for autoimmune diseases
Highlights
- New on EvolcAdded 2026-11-11
About Kalsiom
Kalsiom is a biotech company developing first-in-class monoclonal antibodies that modulate calcium-signaling pathways in lymphocytes. The therapies target autoimmune disorders involving B-cell dysfunction.
The company is built on expertise in Ca2+ signaling combined with antibody development. Its stated focus is inflammatory autoimmune diseases with unmet medical need.
Kalsiom was founded in April 2020 and is based in Brest, France, where its registered address is located.
Product: First-in-class monoclonal antibodies modulating calcium signaling in lymphocytes, in development for autoimmune disorders.
Jobs at Kalsiom
More biotech & pharma companies
Kcas Bio
Bioanalytical and biomarker testing services for pharmaceutical and biotechnology drug developersKekkan Biologics
Develops antibody biologics for cancer and fibrotic disorders, initially targeting triple-negative breast cancerYoung companyNew on EvolcKeybio
Microbiological testing and regulatory support for industrial product developers and manufacturersKimialys
Biosensing surface chemistry and lateral flow assay development for diagnostics and drug discovery labsNew on EvolcKinnov Therapeutics
Developer of KT-110, an oral drug candidate for alcohol use disorder, in clinical development for addiction treatmentNew on EvolcKreatis
In silico toxicology and ecotoxicology predictions for chemical regulatory dossiers, used in place of animal testingNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.